HIV drug resistance in infants increases with changing prevention of mother-to-child transmission regimens
AIDS Aug 10, 2017
Poppe LK, et al. – The aims are to determine HIV drug resistance (HIVDR) prevalence in Zambian infants upon diagnosis, and to determine how changing prevention of mother–to–child transmission (PMTCT) drug regimens affect drug resistance. findings suggested that HIVDR is on the rise in Zambia and presents a serious problem for the successful lifelong treatment of HIV–infected children. PMTCT seems affecting both the prevalence and strength of resistance. Further research is recommended to determine how to mitigate its role leading to resistance.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries